Quality Of LIfe in COLon cancer (QoLiCOL)
The aim of the present study is to explore QoL preoperatively, after 1, 2 and 5 years to explore and identify symptoms and problems of QoL in colon cancer patients.
As this is an exploratory study many hypotheses have been developed:
- A colon cancer diagnosis may affect quality of life.
- Quality of life may not necessarily be lower in patients with an advanced colon cancer compared to patients with a localized tumour.
- A questionnaire with longitudinal follow-up may detect differences in patient expectations and experiences over time.
- Complications associated with colon cancer treatment may affect quality of life as well as the socioeconomic situation for the patient.
- Preoperative quality of life may affect coping strategies and quality of life 1, 2 and 5 years after initiated colon cancer treatment.
- Patient expectation of cure of the colon cancer influences QoL.
- Gender, age and education level may influence QoL during treatment and follow up.
- The primary end-point is to describe QoL, symptoms and functional impairments in an unselected population of colon cancer patients
- Generate basic descriptive data of the patient population, such as demography, socioeconomic data, disease stage at diagnosis, type of treatment, recurrence and survival.
- Compare differences in QoL between patients with different tumour levels.
- Detect differences in QoL in patients over time after colon cancer treatment.
- Evaluate the effect of complications after colon cancer surgery on the patients socioeconomic situation.
- Evaluate the effect of coping strategies on QoL after initiated treatment.
- Describe patient expectations at diagnosis of colon cancer.
- Identify differences in QoL between patients in different groups regarding gender, age and education level.
- Analyse how clinical factors like oncologic result of operation, morbidity, recurrence and survival influence QoL.
- Identify areas of improvement in treatment and patient care.
- Enable initiation interventional studies when appropriate.
- Analyse health economy aspects of QoL and morbidity in the patient population.
- All patients presenting at the participating hospitals with a newly diagnosed colon cancer, regardless of stage at diagnosis and treatment, will be eligible for inclusion.
- Age below18 years at diagnosis.
- No informed consent received or withdrawal of informed consent.
Inclusion of patients:
Aiming at including 1500 patients.
Protocol (click on name to view/download): QoLiCOL
Deputy principal investigator:
PI Eva Angenete (email@example.com) or research nurse Elisabeth González (firstname.lastname@example.org)